About SUHA Pharma Consulting
Turning Preclinical Data into Development Decisions
SUHA Pharma Consulting provides independent DMPK, translational pharmacokinetics and drug development consulting to pharmaceutical companies, biotechnology organizations and CROs.
With 10+ years of pharmaceutical industry experience, Sahithi Yerrabelli brings expertise across preclinical in-vivo research, DMPK, toxicokinetics, PK data analysis, translational pharmacokinetics, modeling, simulation and scientific reporting.
Our strength lies in understanding the complete journey of a drug candidate—from animal dosing and sample collection to PK analysis, translational prediction and development-focused reporting.
“We don’t just analyze numbers. We translate pharmacokinetic data into insights that support better development decisions.”
Expertise at a glance
10+ Years
Pharmaceutical experience
DMPK
Preclinical & translational expertise
Phoenix WinNonlin + R
PK data analysis
Modeling & Simulation
Development support
Why Partner With SUHA Pharma Consulting?
- 10+ years of pharmaceutical industry experience
- End-to-end preclinical PK/DMPK expertise
- Phoenix WinNonlin & R-based analysis
- Translational PK and human dose prediction
- Scientific, development-focused interpretation
- Flexible project-based or fractional consulting
- Confidential, client-controlled data exchange
Who We Support
Pharma · Biotech · CROs · R&D Teams · DMPK Teams · Academic & Research Organizations
Supporting organizations that need reliable PK/DMPK analysis, scientific interpretation and translational insight without the overhead of a full-time specialist.
What You Receive
- Clear PK/TK analysis
- Publication-quality graphs and tables
- Scientifically sound interpretation
- Structured technical reports
- Translational insights
- Development-focused recommendations
From data → analysis → interpretation → decision.